Reconsidering fill-and-finish processes in drug manufacturing

Pharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and accelerate time-to-market and as a result reduce the Total Cost of Ownership of fill-and-finish processes.